COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE study.
Fazio N, Gervaso L, Halfdanarson TR, Sonbol M, Eiring RA, Pusceddu S, Prinzi N, Lombardi Stocchetti B, Grozinsky-Glasberg S, Gross DJ, Walter T, Robelin P, Lombard-Bohas C, Frassoni S, Bagnardi V, Antonuzzo L, Sparano C, Massironi S, Gelsomino F, Bongiovanni A, Ranallo N, Tafuto S, Rossi M, Cives M, Rasul Kakil I, Hamid H, Chirco A, Squadroni M, La Salvia A, Hernando J, Hofland J, Koumarianou A, Boselli S, Tamayo D, Mazzon C, Rubino M, Spada F.
Fazio N, et al. Among authors: tamayo d.
Endocr Relat Cancer. 2023 Apr 26;30(6):e220395. doi: 10.1530/ERC-22-0395. Print 2023 Jun 1.
Endocr Relat Cancer. 2023.
PMID: 36930250